ImmunoVaccine Technologies, Inc. (IMV Inc.)
Quick facts
Marketed products
- CPA · Oncology
CPA is a cancer immunotherapy vaccine that stimulates the immune system to recognize and attack cancer cells by presenting tumor-associated antigens.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: